anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Paragraph

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 118,471
Current window 82,441-82,470
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all
18 30 60

Component

82,441-82,470 of 118,471

filter-aware
396
The slide uses direct quotes from a pediatric endocrinologist to undermine the company's commercial narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
398
The slide uses a Q&A format to expose the contradiction between the drug's intended use and its actual clinical viability.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
399
The slide uses direct quotes from an expert consultation to illustrate market resistance.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
400
The slide uses a combination of summary bullet points and verbatim Q&A transcripts to highlight the expert's negative assessment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
401
The slide uses a direct quote to undermine the perceived value of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
402
The slide highlights a potential competitive threat to Vykat from generic diazoxide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
403
The slide highlights a contradiction between the drug's intended use and its physiological impact on a vulnerable patient population.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
404
The slide uses a summary paragraph followed by a direct quote, highlighting the expert's negative sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
405
The slide uses direct quotes from an expert consultation to highlight the drug's perceived lack of efficacy and the barrier of administrative burden.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
409
The slide uses direct quotes to build a narrative of expert doubt.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
412
The slide uses a Q&A transcript format to validate the claim of trial unblinding.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
414
The slide uses Q&A transcript format to build credibility for the thesis that generic substitution is common practice among specialists.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
415
Includes a Q&A transcript snippet highlighting anecdotal evidence.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
02
The slide uses a bilingual quote (English and Japanese) to set a thematic tone for the presentation.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
10
The slide uses strong, accusatory language to frame a technical failure as a financial fraud.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
16
This slide functions as a 'villain critique' or 'expose' of a company's product claims.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
21
The slide uses expert testimony to debunk the market perception of Lasertec as 'Japan's ASML'.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
27
The slide uses investigative research to expose a gap between public PR and private sentiment regarding Lasertec's technology performance at Intel.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
30
The slide uses investigative reporting style to expose a negative relationship between a vendor (Lasertec) and a customer (TSMC).Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
38
The slide presents anecdotal evidence of potential accounting irregularities and operational challenges at Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
39
The slide uses anecdotal evidence from a customer (Marvell) to allege financial and operational mismanagement at Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
41
The slide uses a highly critical, bearish tone, framing Lasertec's growth as ephemeral and its technology as non-production-worthy.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
42
The slide relies heavily on anecdotal evidence from industry executives and field engineers to support the thesis of market exhaustion.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
44
The slide uses a specific customer anecdote to challenge the growth thesis of the company.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
45
The slide uses highly charged, competitive language ('catastrophic', 'game over', 'will disappear') to frame the competitive threat.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
50
This slide functions as a 'villain critique' or 'expose_contradiction' by highlighting the gap between Lasertec's market claims and customer behavior.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
53
The slide uses strong, accusatory language ('fraud', 'epic scam') to frame the findings of an investigative report.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
01
Slide 1
The slide includes a call to action for stakeholders to contact the firm regarding an upcoming FDA Citizen Petition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
11
The slide uses extreme, inflammatory language to attack the subject company and its leadership.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
13
The slide uses aggressive, accusatory language ('fraud', 'hubris', 'one-trick pony') to frame the company negatively.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit